Glaukos Raises Annual Net Sales Outlook; Shares Jump 18%
Glaukos issued higher net sales guidance for the year. Shares rose almost 18% after the bell to $213.90.
By Stephen NakrosisShares of medical technology company Glaukos were trading at new highs after hours after the company issued higher net sales guidance for the year.After the bell, the company's stock had risen almost 18%, to $213.90. The stock touched an all-time high of $191.61 on Aug. 20.Glauko…